Patent GB-1240169-A (GB)
Title: Furanosides, process for their preparation and compositions containing them
IPC: A61K31/70
Filed: 1968-09-09
Abstract: 1,240,169. Furanosides. CIBA GEIGY A.G. 9 Sept., 1968 [11 Sept., 1967; 25 April, 1968], No. 42798/68. Heading C2C. Novel compounds of Formula I in which R 1  represents a C 1-7  aliphatic hydrocarbon radical which may contain hydroxyl or C 1-7  alkoxy groups, or a cycloaliphatic hydrocarbon radical which may contain C 1-7  alkyl groups, or a benzyl radical whose phenyl ring may be substituted, R 2  represents a hydrogen atom or the acyl radical of an organic carboxylic acid, R 3  represents a hydrogen atom or a C 1 _ 7  aliphatic hydrocarbon radical, and R 5  and R 6  each represents a benzyl radical whose phenyl ring may be substituted, with the proviso that when R 3  represents a C 1 _ 7  aliphatic hydrocarbon radical, R 1  and R 3  together contain at least 3 carbon atoms, and salts of such compounds containing a salt-forming group, are prepared by reacting a compound of Formula II wherein R<SP>0</SP> 1  represents a hydroxyl group and R 2  a hydroxyl group or an acyloxy radical wherein acyl denotes the radical of an organic carboxylic acid, or R<SP>0</SP> 1  and R<SP>0</SP> 2  together represent the grouping of formula -O-X-O-, wherein X represents an optionally substituted methylene group, with a compound of formula R 1 -OH in the presence of an acid, or by reacting a D-glucofuranose of Formula II, in which R<SP>0</SP> 1  represents a reactive esterified hydroxyl group and R<SP>0</SP> 2  represents an acyloxy radical, wherein acyl denotes the acyl radical of an organic carboxylic acid, with a compound of the formula R 1 -OH in the presence of an acid acceptor, and, if desired, saturating an unsaturated C 2 _ 7  aliphatic hydrocarbon radical in a resulting compound, and/or, if desired, converting an acyloxy radical in the 2-position in a resulting compound into a free hydroxyl group, and/or, if desired, converting a free hydroxyl group in the 2-position in a resulting compound into a hydroxyl group esterified by an organic carboxylic acid, and/or, if desired, converting a resulting compound having a salt-forming group into a salt or a resulting salt into the free compound, and/or, if desired, splitting a resulting anomer mixture into the individual anomers. Starting materials of Formula II are prepared in known manner. The preparation of the following specific starting materials and intermediates is disclosed in the examples: 1,2 - 0- isopropylidene - 3 - O - (methyl or allyl) - 5,6- di - O - (4 - methylbenzyl) - α - D - glucofuranose, 1,2 - 0 - isopropylidene - 3 - O - (methyl or propyl) - 5,6 - di - O - (4 - chlorobemyi) - α - D- glucofuranose, 1,2 - O - isopropylidene - 3 - O - npropyl - 5,6 - di - O - benzyl - α - D - glucofuranose, 3 - O - n - propyl - 5,6 - di - O - (4 - chlorobenzyl) - D - glucofuranose and its 1,2 - di - O- acetyl derivative, and 2 - O - acetyl - 3 - O - npropyl - 5,6 - di - O - (4 - chlorobenzyl) - D- glucofuranosyl bromide. Pharmaceutical compositions having antiinflammatory and anti-allergic activity, for oral, parenteral or topical administration, comprise a compound of the invention together with a pharmaceutical carrier. Reference has been directed by the Comptroller to Specification 909,278.